MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29

Provided By GlobeNewswire

Last update: Apr 25, 2025

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29

Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, will host a virtual Capital Markets Day for investors and analysts on Tuesday, April 29, 2025. The event will highlight recent financial and clinical milestones and provide future strategic updates.